High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody–positive patients with autoimmune rheumatic disease

Abstract

Autoantibodies against dense fine speckles 70 (DFS70) are found in 10% of healthy individuals, but only in a tiny population of patients with autoimmune rheumatic disease. The antibody may thus be a marker of autoimmune rheumatic disease negativity. To investigate this possibility, we examined the presence of various disease-marker autoantibodies in anti-DFS70 antibody–positive patients with autoimmune rheumatic disease. Serum samples from 500 patients with various types of autoimmune rheumatic disease were examined for anti-DFS70 antibodies by indirect immunofluorescence and immunoblotting. Various disease-marker autoantibodies were measured by enzyme-linked immunosorbent assay. Twenty-two patients were positive for anti-DFS70 antibodies. Eighteen patients also had disease-marker autoantibodies including anti–double stranded DNA, anti-cardiolipin, anti-SS-A, or other antibodies. In one patient with Sjögren syndrome and two patients with dermatomyositis, no disease-marker antibodies were found; however, one patient with dermatomyositis had a concomitant anti-cytoplasmic antibody. All seven systemic lupus erythematosus patients fulfilled the classification criteria for this disease even if anti-nuclear antibody–positive findings were excluded. One patient with morphea had high-titer anti–single stranded DNA antibody. According to this and previous studies, patients with only anti-DFS70 antibody are rarely diagnosed as having autoimmune rheumatic disease. Recognizing dense fine speckle patterns in anti-nuclear antibodies tests is, thus, very important for analysis of laboratory results in rheumatology clinics.

Keywords

anti-DFS70/LEDGF antibody anti-nuclear antibody autoantigen disease marker

Get full access to this article

View all access options for this article.

References

1 Von Muhlen CA Tan EM . Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24: 323 – 358 .

2 Muro Y . Antinuclear antibodies. Autoimmunity 2005; 38: 3 – 9 .

3 Ochs RL Muro Y Si Y Ge H Chan EK Tan EM . Autoantibodies to DFS 70 kD/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 2000; 105: 1211 – 1220 .

4 Shinohara T Singh DP Fatma N . LEDGF, a survival factor, activates stress-related genes. Prog Retin Eye Res 2000; 21: 341 – 358 .

5 Ge H Si Y Roeder RG . Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J 1998; 17: 6723 – 6729 .

6 Maertens G Cherepanov P Pluymers W . LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 2003; 278: 33528 – 33539 .

7 Daniels T Zhang J Gutierrez I . Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate 2005; 62: 14 – 26 .

8 Muro Y . Autoantibodies in atopic dermatitis. J Dermatol Sci 2001; 25: 171 – 178 .

9 Ganapathy V Casiano CA . Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us? Arthritis Rheum 2004; 50: 684 – 688 .

10.

10 Watanabe A Kodera M Sugiura K . Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum 2004; 50: 892 – 900 .

11.

11 Muro Y Ogawa Y Sugiura K Tomita Y . HLA-associated production of anti-DFS70/LEDGF autoantibodies and systemic autoimmune disease. J Autoimmun 2006; 26: 252 – 257 .

12.

12 Dellavance A Viana VS Leon EP Bonfa ES Andrade LE Leser PG . The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern. J Rheumatol 2005; 32: 2144 – 2149 .

13.

13 Tan EM Cohen AS Fries JF . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271 – 1277 .

14.

14 Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725 .

15.

15 Alarcon-Segovia D Villareal M . Classification and diagnostic criteria for MCTD. In: R Kasukawa GC Sharp , (eds). Mixed connective tissue disease and antinuclear antibodies. Amsterdam : Elsevier ; 1987, p. 33–40.

16.

16 Ogawa Y Sugiura K Watanabe A . Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain. J Autoimmun 2004; 23: 221 – 231 .

17.

17 Okamoto M Ogawa Y Watanabe A . Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J Autoimmun 2004; 23: 257 – 266 .

18.

18 Falanga V Medsger TA Reichlin M . Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 1987; 123: 350 – 353 .

19.

19 Sugiura K Muro Y Tomita Y . A case of a childhood linear scleroderma with limb asymmetry. Mod Rheumatol 2004; 14: 254 – 256 .

20.

20 Nishizawa Y Usukura J Singh DP Chylack LT Shinohara T . Spatial and temporal dynamics of two alternatively spliced regulatory factors, lens epithelium-derived growth factor (LEDGF/p75) and p52, in the nucleus. Cell Tissue Res 2001; 305: 107 – 114 .

21.

21 Kubo E Singh DP Fatma N . Cellular distribution of lens epithelium-derived growth factor (LEDGF) in the rat eye: loss of LEDGF from nuclei of differentiating cells. Histochem Cell Biol 2003; 119: 289 – 299 .

22.

22 Sugiura K Muro Y Nishizawa Y . LEDGF/DFS70, a major autoantigen of atopic dermatitis, is a component of keratohyalin granules. J Invest Dermatol 2007; 127: 75 – 80 .

23.

23 Targoff IN . Idiopathic inflammatory myopathy: autoantibody update. Curr Rheumatol Rep 2002; 4: 434 – 441 .

24.

24 Koenig M Fritzler MJ Targoff IN Troyanov Y Senecal JL . Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 2007; 9: R78 .

25.

25 Arbuckle MR McClain MT Rubertone MV . Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526 – 1533 .

26.

26 Goto N Sugiura K Ogawa Y . Anti-p80 coilin autoantibodies react with a conserved epitope and are associated with anti-DFS70/LEDGF autoantibodies. J Autoimmun 2006; 26: 42 – 51 .